COMMUNIQUÉS West-GlobeNewswire

-
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation
20/03/2025 - 14:00 -
BON Announces Revolutionary Postbiotic Blood Sugar Solution Nears Patent Launch
20/03/2025 - 14:00 -
Longeveron® Announces Positive Type B Meeting with U.S. FDA Regarding Pathway to BLA for Laromestrocel (Lomecel-BTM) in Alzheimer’s Disease
20/03/2025 - 14:00 -
Precision Optics Appoints Joseph P. Pellegrino, Jr. to Board of Directors
20/03/2025 - 14:00 -
Assertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025
20/03/2025 - 14:10 -
Precision Medicine Surge: KFSHRC Achieves 39% Rise in Genetic Mutation Analysis
20/03/2025 - 14:14 -
Transporting Sterile Medical Devices – AAMI Sterilization Guidance
20/03/2025 - 14:20 -
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
20/03/2025 - 14:30 -
Can-Fite Partner Vetbiolix Accelerate Piclidenoson Development with Advanced Clinical Trial for Canine Osteoarthritis in a $3.8 Billion Market
20/03/2025 - 14:45 -
U.S. Oral Surgery Management Enters Wisconsin Market
20/03/2025 - 14:45 -
Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy
20/03/2025 - 15:00 -
WAKE RADIOLOGY'S NEWEST MOBILE MRI UNIT IS NOW ON THE ROAD, PROVIDING GREATER ACCESS TO THE COMMUNITIES THEY SERVE WHILE DELIVERING THE LATEST IN CUTTING-EDGE TECHNOLOGY ACROSS THE TRIANGLE AREA
20/03/2025 - 15:18 -
PathAI Announces EMA Qualification for AIM-MASH AI Assist, a Groundbreaking AI Tool for MASH Clinical Trials
20/03/2025 - 17:00 -
Cylinder acquires Dieta Health, AI-powered stool imaging technology, to advance AI-driven digestive care
20/03/2025 - 17:00 -
Amphista Therapeutics to present novel mechanism of action for the degradation of BRD9 using its proprietary Targeted Glue® technology at two key upcoming scientific conferences
20/03/2025 - 12:00 -
Koelis Announces Innovative Products at EAU 2025 enhancing MRI Fusion Biopsy Workflows and promoting Focal Therapy in Prostate Cancer
20/03/2025 - 12:00 -
Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update
20/03/2025 - 12:00 -
PurDentix Under Review: The Truth About PurDentix and Its Mineral Ritual for Oral Health
20/03/2025 - 12:02 -
Clearside Biomedical’s Lead Clinical Program CLS-AX in Wet AMD and Suprachoroidal Delivery Platform Highlighted at the 2025 Wet AMD & Diabetic Eye Disease Summit
20/03/2025 - 12:05
Pages